Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 74 record(s)

Req # A-2021-000170

Copy of the documentation or studies used by Health Canada in issuing incident report RA-75309 dated April 2, 2021 titled "Face masks that contain graphene may pose a health risk". Copy of all documents containing the results from the preliminary analysis completed by Health Canada in this regard.

Organization: Public Health Agency of Canada

0 page(s)
July 2021

Req # A-2021-000204

Documents that address Public Health Agency of Canada (PHAC) protocols for interception or seizure of ibogaine, including, but not limited to, agency protocols for: training related to the seizure of ibogaine, search, notification, testing, storage, destruction, return or forfeiture. Timeline: July 1 2018 to July 15 2021.

Organization: Public Health Agency of Canada

0 page(s)
July 2021

Req # A-2020-000318

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 19-122268-181, Canada’s Interim Response to the Concluding Observations of the United Nations Committee against Torture.

Organization: Public Health Agency of Canada

31 page(s)
July 2021

Req # A-2021-000093

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-104206-959, Funding Request: COVID-19 Vaccine Misinformation and Disinformation Funding.

Organization: Public Health Agency of Canada

5 page(s)
July 2021

Req # A-2021-000110

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-103753-113, Exercise Decision to Not Purchase Eli Lilly Canada Inc., bamlanivimab, March 2021 Allotment.

Organization: Public Health Agency of Canada

3 page(s)
July 2021

Req # A-2021-003

Please provide all final records, files, and documents, including electronic correspondence and data, sent/rec'd by of former Canada Infrastructure Bank CEO Pierre Lavallée, generated between the start of January 2020 and end of April 2020, carrying or mentioning any of the quoted terms: "resignation" "termination" "severance" “audit” “review”. Search through electronic records only. Exclude cabinet confidences. Remove French versions if English exists. Final version of documents or last draft if final version is not available.

Organization: Canada Infrastructure Bank

0 page(s)
July 2020

Req # A-2020-000040

A list of all individuals and their positions granted approval by the Minister to enter Canada under powers granted via Orders-in-Council, since March 26, 2020.

Organization: Public Health Agency of Canada

0 page(s)
July 2020

Req # A-2020-000111

Public Health Agency of Canada National Microbiology Laboratory (PHAC NML) Ottawa Occupational Safety and Health (OSH) Committee Minutes and Reports for years: 2010, 2011, 2012, 2013, 2014, located in Health Protection Building, 200 Tunney's Pasture dr. Ottawa.

Organization: Public Health Agency of Canada

0 page(s)
July 2020

Req # A-2020-000116

All records between Dr. Theresa Tam, Chief Public Health Officer of Canada and Dr. Anthony Fauci, director of the US National Institute of Allergy and Infectious Diseases, and/or Dr. Robert Redfield, director of the US Centers for Disease Control and Prevention from January 1 to June 16, 2020.

Organization: Public Health Agency of Canada

0 page(s)
July 2020

Req # A-2020-000118

Every record pertaining, in whole or in part, to the pharmaceutical drug prescribed and/or sold using the name Truvada or its non-brand name components, also known as Pre-exposure prophylaxis (PrEP).

Organization: Public Health Agency of Canada

0 page(s)
July 2020
Date modified: